Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 11Terminated 3Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Lymphoma, Non-Hodgkin 2Hodgkin Disease 2Waldenstrom Macroglobulinemia 1Sezary Syndrome 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Mycosis Fungoides 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma, AIDS-Related 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Large Granular Lymphocytic 1Leukemia, Hairy Cell 1Intraocular Lymphoma 1Immunoblastic Lymphadenopathy 1Gliosarcoma 1Glioblastoma 1Central Nervous System Neoplasms 1Burkitt Lymphoma 1

Interventions

Temozolomide 3Magnetic Resonance Spectroscopy 3Radiotherapy 2Radiation 2Carmustine 2Carboplatin 2pazopanib 1gallium Ga 68 dotatate 1ficlatuzumab 1cabazitaxel 1Triiodothyronine 1TIC10 compound 1Sunitinib 1Sorafenib 1Procarbazine 1O(6)-benzylguanine 1Nivolumab 1Methimazole 1Magnetic Resonance Imaging 1Lomustine 1Isotretinoin 1Irinotecan 1Gadolinium DTPA 1Filgrastim 1Biopsy 1Axitinib 12-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Gliosarcoma × O(6)-benzylguanine × Clear all
NCT00046878 2013-03-28

Carmustine and O(6)-Benzylguanine in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme

Duke University

Phase 2 Withdrawn
CNSSarcoma

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡